Top

Journal of Neuro-Oncology

Published in:

01-06-2013 | Letter to the Editor

‘Elderly’ patients with newly diagnosed glioblastoma deserve optimal care

Authors: Matthias Holdhoff, Gary L. Rosner, Sara Alcorn, Stuart A. Grossman

Published in: Journal of Neuro-Oncology | Issue 2/2013

Excerpt

To the Editor, …

Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M et al (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707–715. doi:10.1016/S1470-2045(12)70164-X PubMedCrossRef

Malmstrom A, Gronberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME et al (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916–926. doi:10.1016/S1470-2045(12)70265-6 PubMedCrossRef

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. doi:10.1056/NEJMoa043330 PubMedCrossRef

Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. doi:10.1016/S1470-2045(09)70025-7 PubMedCrossRef

Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(Suppl 5):v1–v49. doi:10.1093/neuonc/nos218 PubMedCrossRef

Yovino S, Grossman SA (2011) Treatment of glioblastoma in “elderly” patients. Curr Treat Options Oncol 12:253–262. doi:10.1007/s11864-011-0158-0 PubMedCrossRef

Title: ‘Elderly’ patients with newly diagnosed glioblastoma deserve optimal care
Authors: Matthias Holdhoff
Gary L. Rosner
Sara Alcorn
Stuart A. Grossman
Publication date: 01-06-2013
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2013
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-013-1113-7

At a glance: The STEP trials

Springer Medicine

‘Elderly’ patients with newly diagnosed glioblastoma deserve optimal care

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2013

Expression level of human miR-34a correlates with glioma grade and prognosis

Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth

Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial

Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution

Hypoxia-induced expression of VE-cadherin and filamin B in glioma cell cultures and pseudopalisade structures

Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease